BioCentury
ARTICLE | Clinical News

CardioPET: Phase II data

February 24, 2014 8:00 AM UTC

An open-label, Belgian Phase II trial in 15 CAD patients showed that CardioPET was well tolerated. FluoroPharma said image quality was "excellent" and image time as early as 3 minutes post-injection. ...